You have 9 free searches left this month | for more free features.

Condition

Major Depressive Disorder (1)

Schizophrenia (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Sirtsei Pharmaceuticals, Inc. (2)

Collaborator

Intervention

placebo (2)

sp-624 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

sp-624

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia Trial in Garden Grove, Marlton (SP-624, Placebo)

Completed

Schizophrenia

SP-624
Placebo

Garden Grove, California
+1 more

Apr 18, 2022

MDD Trial in United States (SP-624, Placebo)

Active, not recruiting

Major Depressive Disorder

SP-624
Placebo

Phoenix, Arizona
+38 more

May 13, 2022